Le Lézard
Classified in: Health
Subject: CPG


MONTRÉAL, Sept. 28, 2023 /CNW/ - Exactly 25 years ago, on September 28, 1998, the Québec government created Héma-Québec, which became the exclusive supplier for blood products and medications manufactured from plasma for people in the province. Since then, the organization has continued to grow steadily, notably by creating new lines of business such as those of stem cells, human tissues, mothers' milk, and specialized laboratory services. Today, Héma-Québec, an essential partner in the health care system, is proud of the important social role it plays in the lives of Quebeckers.

To underscore this quarter century of achievement, this fall, the organization launched a microsite that hosts a podcast, Donneurs de sens, including nine episodes filled with information about various aspects of the organization's mission. The anniversary will also be in the spotlight during various events organized this year for donors, volunteers, employees, and partners.

"Without all the members of the great Héma-Québec family, nothing of all that has been accomplished in the past 25 years would have been possible," said Nathalie Fagnan, President and CEO. "Together, we must take advantage of these milestones to take a step back and encourage each other to continue to give our best. It is also an opportunity to look to the future because we aren't short on projects and especially ambition to continue developing and always doing better, in serving Québec's population." 

About Héma-Québec
Héma-Québec's mission is to efficiently meet the Québec population's needs for blood and other high-quality biological products of human origin. Héma-Québec has over 1,600 employees, more than 200,000 donors of blood, stem cells, mother's milk and human tissues, as well as thousands of blood drive volunteers. Every year, Héma-Québec delivers nearly 800,000 biological products of human origin to Québec's hospitals in order to meet patients' needs.

Give blood. Give life.


SOURCE Héma-Québec

These press releases may also interest you

at 21:30
The "Hydroxypropyl Methylcellulose Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to  ResearchAndMarkets.com's offering. The latest industry analysis on the Hydroxypropyl Methylcellulose...

at 21:00
The "Asia-Pacific Contrast Media Agent and Injector System Market - Analysis and Forecast, 2022-2026" report has been added to  ResearchAndMarkets.com's offering. The Asia-Pacific contrast media agent and injector system market was valued at $1.98...

at 20:50
Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the pricing of its  underwritten public offering of 6,471,000...

at 20:34
The Honourable Mark Holland, Minister of Health, will make an announcement related to An Act Respecting Pharmacare. There will be a virtual media technical briefing with Government of Canada officials prior to the press conference. DateFebruary 29,...

at 19:30
The "Protein Expression Market - A Global and Regional Analysis: Focus on Application, End User, Product, Expression System, and Region - Analysis and Forecast, 2023-2033" report has been added to  ResearchAndMarkets.com's offering. The global...

at 19:20
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, today announced that MSCI, one of the...

News published on and distributed by: